Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Receivables - Net (2022 - 2025)

Historic Receivables - Net for Coeptis Therapeutics Holdings (COEPW) over the last 3 years, with Q3 2025 value amounting to $82500.0.

  • Coeptis Therapeutics Holdings' Receivables - Net changed N/A to $82500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $82500.0, marking a year-over-year change of. This contributed to the annual value of $8075.0 for FY2022, which is N/A changed from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Receivables - Net stood at $82500.0 for Q3 2025.
  • Coeptis Therapeutics Holdings' 5-year Receivables - Net high stood at $461905.0 for Q2 2023, and its period low was $8075.0 during Q4 2022.
  • Moreover, its 3-year median value for Receivables - Net was $56250.0 (2025), whereas its average is $145620.0.